Melchers F
Biochem J. 1970 Oct;119(4):765-72. doi: 10.1042/bj1190765.
The kinetics of incorporation of leucine, galactose and mannose into intracellular and secreted myeloma protein, MOPC 21 IgG(1) and MOPC 46 kappa-type light chain, by cell suspensions of two myeloma plasma-cell tumours, MOPC 21 and MOPC 46, were similar. Radioactive galactose was incorporated to over 90% into galactose residues of intracellular and secreted protein, mannose to over 90% into glucosamine and mannose residues of intracellular protein and to over 90% into glucosamine, mannose and fucose residues of secreted protein, but not into galactose residues. The results show that specific residues in the carbohydrate portion of myeloma proteins can be labelled by specific radioactive monosaccharides, and suggest that fucose residues are added, while myeloma protein is in its final stage of secretion from the plasma cell. The kinetics of incorporation indicate at least three sequential precursor-product relationships between different intracellular forms and the secreted form of myeloma protein.
两种骨髓瘤浆细胞瘤MOPC 21和MOPC 46的细胞悬液将亮氨酸、半乳糖和甘露糖掺入细胞内及分泌型骨髓瘤蛋白MOPC 21 IgG(1)和MOPC 46 κ型轻链的动力学相似。放射性半乳糖超过90%掺入细胞内及分泌型蛋白的半乳糖残基,甘露糖超过90%掺入细胞内蛋白的葡糖胺和甘露糖残基,超过90%掺入分泌型蛋白的葡糖胺、甘露糖和岩藻糖残基,但不掺入半乳糖残基。结果表明,骨髓瘤蛋白碳水化合物部分的特定残基可被特定放射性单糖标记,提示在骨髓瘤蛋白从浆细胞分泌的最后阶段添加了岩藻糖残基。掺入动力学表明,骨髓瘤蛋白不同细胞内形式与分泌形式之间至少存在三种连续的前体-产物关系。